← SynDRA
AZD-4017
SynDRA canonical compound SYN0033973 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GGT1 | HSD11B1 |
|---|
| Mechanism of action | 11-beta hydroxysteroid dehydrogenase inhibitor |
|---|
| Indication | obesity |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- HSD11B1 INHIBITOR
- 11-beta-hydroxysteroid dehydrogenase 1 inhibitor
- 11-beta hydroxysteroid dehydrogenase inhibitor
Cross-references
Synonyms
- AZD 4017
- AZD4017
- CHEMBL2153191
- AZD-4017 (oral tablet, ocular hypertension)
- 3JL137394Y
- RefChem:115998
- DTXCID2067535
- UNII-3JL137394Y
- GTPL7695
- orb1308605
- SCHEMBL1967349
- C22H33N3O3S
- AZD 4017 [WHO-DD]
- GLXC-15623
- BDBM50392216
- MFCD25976912
- AKOS025396017
- EBC-510538
- BA166507
- DA-50847
- HY-18053
- MS-27355
- CS-0007200
- F18726
- T14388
- US8673938, 7
- AZD4017; AZD-4017; AZD 4017
Look up AZD-4017 in the interactive SynDRA portal →